Tirzepatide (Mounjaro®) will be

available to access in primary care

settings

From 23 June 2025, following approval by NICE, tirzepatide (Mounjaro®) will

be available to access in primary care settings.

NICE directed the NHS to make tirzepatide (Mounjaro®) available as a

treatment option for the management of obesity, for up to 220,000 over the

next three years.

The 24 March 2025 saw tirzepatide (Mounjaro®) introduced as a treatment

option in Secondary Weight Management Services (SWMS).  From 23 June,

primary care settings will begin offering access to tirzepatide (Mounjaro®)

as a potential treatment option, for the management of obesity.  Patients

will be able to begin the process of accessing the drug to improve their

health through supported weight loss. Weight management services are

locally commissioned and funded by the ICB, meaning services will differ

across ICBs.

FAQS - Prescribing of Tirzepatide for

Weight Loss

Please find a set of Frequently Asked Questions describing the eligibility

criteria and prescribing and lifestyle support approach being taken for

patients to access  Tirzepatide (also called Mounjaro®) for weight loss.  The

FAQs are divided into two sections:

• FAQs to respond to questions raised from General Practice, these should
• be read alongside;
• Public FAQs – which are also published on the ICB website and you can
• link to from your Practice Website

Background

Across England, including Cheshire and Merseyside, access to the

medication is being phased and prioritised to ensure patients with the

greatest clinical need can receive it.

Cohort 1 – will start in the summer of 2025 in response to the requirement

of NICE to make this drug available in “Primary Care Settings”.  GPs should

not directly prescribe tirzepatide for weight loss. The ICB is in the process

of commissioning community/primary care weight loss prescribing services

so that GPs have somewhere to refer eligible patients in line with the NICA

TA1026 and NHS England Commissioning Guidance.  As soon as these are

available we will update you, we are looking to implement these as soon as

possible.

The FAQs describe eligibility but for clarity the national roll out set by NHS

England mean access this year is only for people with at least 4 of the 5

health conditions listed below plus a BMI of at least 40 (BMI to be

adjusted for ethnicity*).

The following weight-related health conditions will be used to define

those who are eligible first:

• type 2 diabetes mellitus
• high blood pressure
• heart disease
• obstructive sleep apnoea (when your breathing stops and starts while you
• sleep)
• abnormal blood fats (dyslipidaemia)

Did you know that we work collaboratively as part of South Primary Care Network, and within our primary care network we have several different roles that work across each practice on different days which allows us to book our patients extra appointments.

Sometimes this means that appointments can be booked by us but may be held at some of the following locations :

Stretton Medical Centre

Stockton Heath Medical Centre

Latchford Medical Centre

Brookfield Surgery

Lakeside surgery

Orford Jubilee

Some of the roles that work across our PCN (primary Care Newtwork) are:

Prescribing Paramedics

Mental Health Nurses

Clincal Pharmacists

First Contact Physio

Advanced nurse practicioners

GP

We would like to start our PPG meetings again, but as a fairly new Practice Manager here to stretton medical centre i would like to get to know our local PPG members:

If you would like to join or are already part of our PPG and would like to speak to me about our next meeting them please get in touch on : 

01925 599856

or 

cmicb-war.strettonmc@nhs.net

Thanks 

Lauren - Practice Manager 

https://strettonmedicalcentre.webgp.com/